MedKoo Cat#: 526370 | Name: Sudoxicam

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Sudoxicam is a nonsteroidal anti-inflammatory drugs (NSAIDs) from the enol-carboxamide class.

Chemical Structure

Sudoxicam
Sudoxicam
CAS#34042-85-8

Theoretical Analysis

MedKoo Cat#: 526370

Name: Sudoxicam

CAS#: 34042-85-8

Chemical Formula: C13H11N3O4S2

Exact Mass: 337.0191

Molecular Weight: 337.37

Elemental Analysis: C, 46.28; H, 3.29; N, 12.46; O, 18.97; S, 19.01

Price and Availability

Size Price Availability Quantity
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
Sudoxicam; CP-15,973; CP 15,973; CP15,973; CP-15973; CP 15973; CP15973; NSC 615046; Normeloxicam;
IUPAC/Chemical Name
4-Hydroxy-2-methyl-N-2-thiazolyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide
InChi Key
SYCHUQUJURZQMO-UHFFFAOYSA-N
InChi Code
InChI=1S/C13H11N3O4S2/c1-16-10(12(18)15-13-14-6-7-21-13)11(17)8-4-2-3-5-9(8)22(16,19)20/h2-7,17H,1H3,(H,14,15,18)
SMILES Code
O=C(C1=C(O)C2=CC=CC=C2S(N1C)(=O)=O)NC3=NC=CS3
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Product Data
Biological target:
Sudoxicam is a reversible and orally active COX antagonist.
In vitro activity:
To be determined
In vivo activity:
To be determined

Preparing Stock Solutions

The following data is based on the product molecular weight 337.37 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
To be determined
In vitro protocol:
To be determined
In vivo protocol:
To be determined
1: Obach RS, Kalgutkar AS, Ryder TF, Walker GS. In vitro metabolism and covalent binding of enol-carboxamide derivatives and anti-inflammatory agents sudoxicam and meloxicam: insights into the hepatotoxicity of sudoxicam. Chem Res Toxicol. 2008 Sep;21(9):1890-9. doi: 10.1021/tx800185b. PubMed PMID: 18707140. 2: Hobbs DC, Twomey TM. Metabolism of sudoxicam by the rat, dog, and monkey. Drug Metab Dispos. 1977 Jan-Feb;5(1):75-81. PubMed PMID: 13979. 3: Wiseman EH, Chang YH, Hobbs DC. Interaction of sudoxicam and aspirin in animals and man. Clin Pharmacol Ther. 1975 Oct;18(4):441-8. PubMed PMID: 809225. 4: Constantine JW, Purcell IM. Inhibition of platelet aggregation and of experimental thrombosis by sudoxicam. J Pharmacol Exp Ther. 1973 Dec;187(3):653-65. PubMed PMID: 4770405. 5: Wiseman EH, Chiaini J. Anti-inflammatory and pharmacokinetic properties of sudoxicam N-(2-thiazolyl)-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide. Biochem Pharmacol. 1972 Sep 1;21(17):2323-34. PubMed PMID: 4630489. 6: Lombardino JG, Wiseman EH. Sudoxicam and related N-heterocyclic carboxamides of 4-hydroxy-2H-1,2-benzothiazine 1,1-dioxide. Potent nonsteroidal antiinflammatory agents. J Med Chem. 1972 Aug;15(8):848-9. PubMed PMID: 4625532.